PROS1 and infection: The high level of neutralizing antibody production against the S protein during natural infections, especially against the Receptor Binding Domain (RBD) (Sun et al., 2020; Achiron et al., 2021), demonstrates the potential of the S protein, or fragments derived from it, as a target antigen in serological tests.